srne stock price news

Earnings Data Monitor earnings expectations over the past three quarters and model a stocks price based on its PE. NASDAQ Updated Feb 24 2022 1136 AM.

Srne Institutional Ownership Sorrento Therapeutics Inc Nasdaq Stock

Ad 1000 Strong Buy Stocks that Double the SP.

. Today 52-Week Range. Get a full understanding of how Sorrento Therapeutics Inc. Over the past 145 months SRNEs EVEBIT ratio has gone up 399.

261 005 19531 as of 40000pm ET 02242022. ET View Interactive SRNE Charts. Sorrento Therapeutics Inc SRNE Stock Price News - Google Finance.

The stock has traded between 226 and 245 so far today. SRNE Sorrento Therapeutics Inc. Get the latest Sorrento Therapeutics Inc.

This suggests a possible upside of 8579 from the stocks current price. Find the latest Sorrento Therapeutics Inc SRNE stock market data. Sorrento Therapeutics Inc SRNE stock is trading at 227 as of 246 PM on Thursday Mar 3 a decline of -014 or -581 from the previous closing price of 241.

Nasdaq Capital Market Nasdaq SRNE. A high-level overview of Sorrento Therapeutics Inc. Read news commentary analysis and events related to SORRENTO THERAPEUTICS INC SRNE.

SRNE stock news and headlines to help you in your trading and investing decisions. Get Sorrento Therapeutics Inc SRNENASDAQ real-time stock quotes news price and financial information from CNBC. Srne Price Discussion It just seems the market jumped in and bought this stock very aggressively when COVID-19 made its way back in 2020 and we were known as COVID STOCK and it seems as COVID is controlled and more solutions came to the market and the agenda of COVID Omicron cooled off people has been pulling money away from this stock.

SRNE investment stock information. Considering analysts have assigned the stock a price target range of 1800-2600 as the low and high respectively we find the trailing 12-month average consensus price target to be 2200. Stock Price and Discussion Stocktwits.

Sorrento Therapeutics Inc. PE Ratio TTM The Price to Earnings PE ratio. SRNE 256 022 791 Pre-Market 018 703 70880.

SRNE Complete Sorrento Therapeutics Inc. No significant news for in the past two years. Add to Watch List.

1 equities research analysts have issued 12 month target prices for Sorrento Therapeutics stock. Their forecasts range from 2500 to 2500. Stock news by MarketWatch.

Below are key valuation metrics over time for SRNE. News Sorrento Therapeutics IncSRNE. Quotes delayed at least 15 min.

Over the past 145 months SRNEs pricesales ratio has gone NA NA. Price as of February 18 2022 400 pm. NASDAQSRNEs beta value is holding at 237 while the average true range ATR indicator is currently reading 026.

SRNEs priceearnings ratio is -84. View real-time stock prices and stock quotes for a full financial overview. Is performing with stock quotes and prices as well as real-time.

Find the latest Sorrento Therapeutics Inc. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Get the latest Sorrento Therapeutics Inc.

View Sorrento Therapeutics Inc. Log in for real time quote. News Events.

SRNE stock quote history news and other vital information to help you with your stock trading and investing. Sorrento Therapeutics Inc NASDAQSRNE Sorrento Therapeutics Inc. View real-time stock prices and stock quotes for a full financial overview.

On average they anticipate Sorrento Therapeutics stock price to reach 2500 in the next twelve months. As of 400pm ET. Volume today is below average.

This is 12301 lower than that of the median Healthcare stock. Stock news by MarketWatch. SRNE Complete Sorrento Therapeutics Inc.

Utdpwa6bbal95m